Bence Hegyi1, Ye Chen-Izu1,2,3, Leighton T Izu1, Sridharan Rajamani4, Luiz Belardinelli5, Donald M Bers1, Tamás Bányász1,6. 1. Department of Pharmacology (B.H., Y.C.-I., L.T.I., D.M.B., T.B.), University of California, Davis. 2. Department of Biomedical Engineering (Y.C.-I.), University of California, Davis. 3. Department of Internal Medicine/Cardiology (Y.C.-I.), University of California, Davis. 4. Amgen, Inc, South San Francisco (S.R.). 5. InCarda Therapeutics, Inc, Newark, CA (L.B.). 6. Department of Physiology, Faculty of Medicine, University of Debrecen, Hungary (T.B.).
Abstract
BACKGROUND: Rapid delayed rectifier K+ current (IKr) and late Na+ current (INaL) significantly shape the cardiac action potential (AP). Changes in their magnitudes can cause either long or short QT syndromes associated with malignant ventricular arrhythmias and sudden cardiac death. METHODS: Physiological self AP-clamp was used to measure INaL and IKr during the AP in rabbit and porcine ventricular cardiomyocytes to test our hypothesis that the balance between IKr and INaL affects repolarization stability in health and disease conditions. RESULTS: We found comparable amount of net charge carried by IKr and INaL during the physiological AP, suggesting that outward K+ current via IKr and inward Na+ current via INaL are in balance during physiological repolarization. Remarkably, IKr and INaL integrals in each control myocyte were highly correlated in both healthy rabbit and pig myocytes, despite high overall cell-to-cell variability. This close correlation was lost in heart failure myocytes from both species. Pretreatment with E-4031 to block IKr (mimicking long QT syndrome 2) or with sea anemone toxin II to impair Na+ channel inactivation (mimicking long QT syndrome 3) prolonged AP duration (APD); however, using GS-967 to inhibit INaL sufficiently restored APD to control in both cases. Importantly, INaL inhibition significantly reduced the beat-to-beat and short-term variabilities of APD. Moreover, INaL inhibition also restored APD and repolarization stability in heart failure. Conversely, pretreatment with GS-967 shortened APD (mimicking short QT syndrome), and E-4031 reverted APD shortening. Furthermore, the amplitude of AP alternans occurring at high pacing frequency was decreased by INaL inhibition, increased by IKr inhibition, and restored by combined INaL and IKr inhibitions. CONCLUSIONS: Our data demonstrate that IKr and INaL are counterbalancing currents during the physiological ventricular AP and their integrals covary in individual myocytes. Targeting these ionic currents to normalize their balance may have significant therapeutic potential in heart diseases with repolarization abnormalities. Visual Overview: A visual overview is available for this article.
BACKGROUND: Rapid delayed rectifier K+ current (IKr) and late Na+ current (INaL) significantly shape the cardiac action potential (AP). Changes in their magnitudes can cause either long or short QT syndromes associated with malignant ventricular arrhythmias and sudden cardiac death. METHODS: Physiological self AP-clamp was used to measure INaL and IKr during the AP in rabbit and porcine ventricular cardiomyocytes to test our hypothesis that the balance between IKr and INaL affects repolarization stability in health and disease conditions. RESULTS: We found comparable amount of net charge carried by IKr and INaL during the physiological AP, suggesting that outward K+ current via IKr and inward Na+ current via INaL are in balance during physiological repolarization. Remarkably, IKr and INaL integrals in each control myocyte were highly correlated in both healthy rabbit and pig myocytes, despite high overall cell-to-cell variability. This close correlation was lost in heart failure myocytes from both species. Pretreatment with E-4031 to block IKr (mimicking long QT syndrome 2) or with sea anemone toxin II to impair Na+ channel inactivation (mimicking long QT syndrome 3) prolonged AP duration (APD); however, using GS-967 to inhibit INaL sufficiently restored APD to control in both cases. Importantly, INaL inhibition significantly reduced the beat-to-beat and short-term variabilities of APD. Moreover, INaL inhibition also restored APD and repolarization stability in heart failure. Conversely, pretreatment with GS-967 shortened APD (mimicking short QT syndrome), and E-4031 reverted APD shortening. Furthermore, the amplitude of AP alternans occurring at high pacing frequency was decreased by INaL inhibition, increased by IKr inhibition, and restored by combined INaL and IKr inhibitions. CONCLUSIONS: Our data demonstrate that IKr and INaL are counterbalancing currents during the physiological ventricular AP and their integrals covary in individual myocytes. Targeting these ionic currents to normalize their balance may have significant therapeutic potential in heart diseases with repolarization abnormalities. Visual Overview: A visual overview is available for this article.
Entities:
Keywords:
Brugada syndrome; action potential; heart; long QT syndrome; tetrodotoxin
Authors: A József Szentmiklosi; Norbert Szentandrássy; Bence Hegyi; Balázs Horvath; János Magyar; Tamás Bányász; Peter P Nanasi Journal: Curr Pharm Des Date: 2015 Impact factor: 3.116
Authors: Bence Hegyi; Balázs Horváth; Krisztina Váczi; Mónika Gönczi; Kornél Kistamás; Ferenc Ruzsnavszky; Roland Veress; Leighton T Izu; Ye Chen-Izu; Tamás Bányász; János Magyar; László Csernoch; Péter P Nánási; Norbert Szentandrássy Journal: J Mol Cell Cardiol Date: 2017-06-29 Impact factor: 5.000
Authors: Balázs Horváth; Bence Hegyi; Kornél Kistamás; Krisztina Váczi; Tamás Bányász; János Magyar; Norbert Szentandrássy; Péter P Nánási Journal: Can J Physiol Pharmacol Date: 2015-02-09 Impact factor: 2.273
Authors: Luiz Belardinelli; Wayne R Giles; Sridharan Rajamani; Hrayr S Karagueuzian; John C Shryock Journal: Heart Rhythm Date: 2014-11-11 Impact factor: 6.343
Authors: Yuko Wada; Tao Yang; Christian M Shaffer; Laura L Daniel; Andrew M Glazer; Giovanni E Davogustto; Brandon D Lowery; Eric H Farber-Eger; Quinn S Wells; Dan M Roden Journal: Circulation Date: 2022-01-07 Impact factor: 29.690
Authors: Anh Tuan Ton; William Nguyen; Katrina Sweat; Yannick Miron; Eduardo Hernandez; Tiara Wong; Valentyna Geft; Andrew Macias; Ana Espinoza; Ky Truong; Lana Rasoul; Alexa Stafford; Tamara Cotta; Christina Mai; Tim Indersmitten; Guy Page; Paul E Miller; Andre Ghetti; Najah Abi-Gerges Journal: Sci Rep Date: 2021-06-08 Impact factor: 4.379
Authors: Christos Charalambous; James C Moon; Jeff M P Holly; Nishi Chaturvedi; Alun D Hughes; Gabriella Captur Journal: Front Cardiovasc Med Date: 2022-04-22
Authors: Bence Hegyi; Risto-Pekka Pölönen; Kim T Hellgren; Christopher Y Ko; Kenneth S Ginsburg; Julie Bossuyt; Mark Mercola; Donald M Bers Journal: Basic Res Cardiol Date: 2021-10-14 Impact factor: 17.165
Authors: Balázs Horváth; Norbert Szentandrássy; Csaba Dienes; Zsigmond M Kovács; Péter P Nánási; Ye Chen-Izu; Leighton T Izu; Tamas Banyasz Journal: Front Physiol Date: 2022-03-16 Impact factor: 4.566